Shares of Startek, Inc. (SRT) Report Q1 Loss; Shares Up Over 50% in Early Trading
Get Alerts SRT Hot Sheet
Price: $4.42 --0%
Revenue Growth %: -100.0%
Financial Fact:
Impairment losses and restructuring charges: 187K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -100.0%
Financial Fact:
Impairment losses and restructuring charges: 187K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Startek, Inc. (NYSE: SRT) reported Q1 EPS of ($0.40) vs. the analyst estimate of ($0.20). Revenue for the quarter came in at $50.86 million, topping the consensus estimate of $46.42 million.
(The Company reported first quarter 2012 adjusted EBITDA of $1.2 million and an operating loss before impairment and restructuring charges of $3.0 million, compared to a fourth quarter 2011 adjusted EBITDA of negative $1.2 million and an operating loss before impairment and restructuring charges of $5.4 million)
For earnings history and earnings-related data on Startek, Inc. (SRT) click here.
(The Company reported first quarter 2012 adjusted EBITDA of $1.2 million and an operating loss before impairment and restructuring charges of $3.0 million, compared to a fourth quarter 2011 adjusted EBITDA of negative $1.2 million and an operating loss before impairment and restructuring charges of $5.4 million)
For earnings history and earnings-related data on Startek, Inc. (SRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!